198 related articles for article (PubMed ID: 69814)
1. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
Mashiter K; Adams E; Beard M; Holley A
Lancet; 1977 Jul; 2(8030):197-8. PubMed ID: 69814
[No Abstract] [Full Text] [Related]
2. Monolayer and suspension culture of human prolactin-secreting pituitary adenoma.
Kletzky OA; Marrs RP; Rundall TT; Weiss MH; Beierle JW
Am J Obstet Gynecol; 1980 Nov; 138(6):660-4. PubMed ID: 7435530
[TBL] [Abstract][Full Text] [Related]
3. Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
Kawamoto K; Uozumi T; Sakoda K; Mukada K; Kurisu K; Yano T
Cancer; 1992 Jun; 69(11):2688-96. PubMed ID: 1571899
[TBL] [Abstract][Full Text] [Related]
4. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
[No Abstract] [Full Text] [Related]
5. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.
Anniko M; Werner S; Wersäll J
Acta Otolaryngol; 1981; 92(3-4):343-55. PubMed ID: 7324902
[No Abstract] [Full Text] [Related]
6. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
Prysor-Jones RA; Kennedy SJ; O'Sullivan JP; Jenkins JS
Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372
[TBL] [Abstract][Full Text] [Related]
7. Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.
Anniko M; Wersäll J
Acta Pathol Microbiol Scand A; 1981 Jan; 89(1):41-7. PubMed ID: 7223426
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
Muechler EK; Huang KE; McDonald JV; Tang L
Am J Obstet Gynecol; 1987 Aug; 157(2):453-5. PubMed ID: 3113252
[TBL] [Abstract][Full Text] [Related]
9. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
[TBL] [Abstract][Full Text] [Related]
10. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Sadoul JL; Thyss A; Freychet P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
[TBL] [Abstract][Full Text] [Related]
11. Effects of two novel dopaminergic drugs, CV 205-502 and CQP 201-403, on prolactin and growth hormone secretion by human pituitary tumours in vitro.
Venetikou MS; Burrin JM; Woods CA; Yeo TH; Brownell J; Adams EF
Acta Endocrinol (Copenh); 1987 Oct; 116(2):287-92. PubMed ID: 3661066
[TBL] [Abstract][Full Text] [Related]
12. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
Lamberts SW; Verleun T; Hofland L; Del Pozo E
Clin Endocrinol (Oxf); 1987 Jul; 27(1):11-23. PubMed ID: 2888550
[TBL] [Abstract][Full Text] [Related]
13. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
Johansen PW; Haug E; Gautvik KM
Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
[TBL] [Abstract][Full Text] [Related]
14. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
Dall'Ara A; Lima L; Cocchi D; Di Salle E; Cancio E; Devesa J; Müller EE
Eur J Pharmacol; 1988 Jun; 151(1):97-102. PubMed ID: 3416930
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of amyloid in pituitary adenomas.
Saitoh Y; Mori H; Matsumoto K; Ushio Y; Hayakawa T; Mori S; Arita N; Mogami H
Acta Neuropathol; 1985; 68(2):87-92. PubMed ID: 3000127
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and prolactin production in human pituitary tumours in organ culture.
Anniko M; Werner S; Wersäll J
Acta Otolaryngol; 1980; 90(1-2):143-51. PubMed ID: 6778067
[TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
[TBL] [Abstract][Full Text] [Related]
19. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
De Camilli P; Macconi D; Spada A
Nature; 1979 Mar; 278(5701):252-4. PubMed ID: 423973
[No Abstract] [Full Text] [Related]
20. Bromocriptine-induced morphological changes in cultured growth hormone-producing pituitary adenoma cells.
Inoue A; Saito S; Kitamura H; Nakai O
Neurol Med Chir (Tokyo); 1989 Jan; 29(1):6-9. PubMed ID: 2472570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
